Stock listing
NASDAQ:ACAD ACADIA Pharmaceuticals Inc. Stock
Home listing (NASDAQ) of ACADIA Pharmaceuticals Inc.
Follow ACADIA Pharmaceuticals Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ACAD
$20.59 USD -0.17 (-0.8%)
Close on Oct 30, 2026
- Day range
- $20.49 – $21.01 USDOct 30, 2026
- Volume
- 1.14M sharesOct 30, 2026
- Market cap
- $3.55B USDAt the close on Oct 30, 2026 · price × 172.3M shares outstanding
- 52-week range
- $18.39 – $30.96 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $45.60M USDMedian day 1.50M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ACAD · Home | $20.59 USD | -0.17 (-0.8%) | 1,137,496 | $20.88 | $21.01 | $20.49 | $20.76 | Close on Oct 30, 2026 |
| Frankfurt:DR6 | €18.44 EUR | +0.785 (+4.4%) | — | €18.26 | €18.44 | €18.26 | €17.66 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:ACAD · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $20.59 | -0.17 | -0.8% | $20.88 | $21.01 | $20.49 | 1,137,496 | |
| $20.76 | +0.44 | +2.2% | $20.61 | $20.88 | $20.50 | 2,193,721 | |
| $20.32 | +0.15 | +0.7% | $20.00 | $20.35 | $20.00 | 1,335,586 | |
| $20.17 | +0.43 | +2.2% | $19.58 | $20.29 | $19.51 | 1,332,124 | |
| $19.74 | +0.01 | +0.1% | $19.72 | $19.89 | $19.59 | 1,229,728 | |
| $19.73 | -0.58 | -2.9% | $20.22 | $20.25 | $19.58 | 1,065,605 | |
| $20.31 | +0.12 | +0.6% | $20.30 | $20.50 | $20.12 | 1,229,380 | |
| $20.19 | -0.25 | -1.2% | $20.44 | $20.54 | $20.10 | 1,409,865 | |
| $20.44 | +0.64 | +3.2% | $20.01 | $20.49 | $19.86 | 1,675,280 | |
| $19.80 | +0.68 | +3.6% | $19.33 | $19.84 | $19.11 | 1,298,117 | |
| $19.12 | -0.59 | -3.0% | $19.76 | $19.76 | $18.87 | 1,672,256 | |
| $19.71 | +0.46 | +2.4% | $19.48 | $19.88 | $19.28 | 1,767,168 | |
| $19.25 | +0.63 | +3.4% | $18.60 | $19.28 | $18.49 | 1,642,771 | |
| $18.62 | -0.79 | -4.1% | $19.05 | $19.10 | $18.39 | 2,140,500 | |
| $19.41 | -0.37 | -1.9% | $19.70 | $19.87 | $19.40 | 1,184,600 | |
| $19.78 | +0.20 | +1.0% | $19.60 | $20.05 | $19.58 | 1,470,100 | |
| $19.58 | -0.07 | -0.4% | $19.46 | $19.79 | $19.32 | 2,006,600 | |
| $19.65 | -0.09 | -0.5% | $19.60 | $19.80 | $19.46 | 1,784,700 | |
| $19.74 | -0.37 | -1.8% | $20.16 | $20.36 | $19.67 | 1,665,700 | |
| $20.11 | +0.16 | +0.8% | $20.05 | $20.45 | $19.57 | 3,152,100 | |
| $19.95 | +0.06 | +0.3% | $20.01 | $20.24 | $19.88 | 2,564,600 | |
| $19.89 | -0.26 | -1.3% | $19.95 | $20.19 | $19.59 | 2,731,500 | |
| $20.15 | -0.07 | -0.3% | $20.28 | $20.70 | $19.93 | 3,134,000 | |
| $20.22 | -0.31 | -1.5% | $20.61 | $20.61 | $20.06 | 2,514,000 | |
| $20.53 | -0.15 | -0.7% | $20.53 | $20.63 | $19.80 | 3,522,800 | |
| $20.68 | -1.50 | -6.8% | $22.21 | $22.21 | $20.61 | 3,363,800 | |
| $22.18 | -3.25 | -12.8% | $24.38 | $24.38 | $21.97 | 6,758,000 | |
| $25.43 | -0.98 | -3.7% | $26.41 | $26.51 | $24.93 | 1,306,100 | |
| $26.41 | +0.01 | 0.0% | $26.65 | $26.86 | $26.32 | 1,472,400 | |
| $26.40 | -0.89 | -3.3% | $27.43 | $27.43 | $26.34 | 1,352,000 | |
| $27.29 | -0.16 | -0.6% | $27.37 | $27.48 | $26.73 | 5,482,700 | |
| $27.45 | -0.09 | -0.3% | $27.78 | $28.06 | $27.29 | 1,307,800 | |
| $27.54 | +0.78 | +2.9% | $26.75 | $27.60 | $26.66 | 1,405,200 | |
| $26.76 | -0.76 | -2.8% | $27.51 | $27.51 | $26.64 | 1,109,200 | |
| $27.52 | -0.31 | -1.1% | $28.00 | $28.10 | $27.38 | 1,628,500 | |
| $27.83 | +0.09 | +0.3% | $27.98 | $28.24 | $27.74 | 1,172,800 | |
| $27.74 | +0.06 | +0.2% | $27.63 | $27.86 | $27.36 | 1,014,600 | |
| $27.68 | +0.10 | +0.4% | $27.44 | $27.95 | $27.40 | 1,293,900 | |
| $27.58 | -0.44 | -1.6% | $27.63 | $28.09 | $27.10 | 1,457,700 | |
| $28.02 | +0.16 | +0.6% | $27.77 | $28.19 | $27.65 | 1,682,900 | |
| $27.86 | -1.07 | -3.7% | $29.00 | $29.07 | $27.62 | 1,849,400 | |
| $28.93 | +0.04 | +0.1% | $29.10 | $29.75 | $28.88 | 1,556,000 | |
| $28.89 | -0.02 | -0.1% | $28.84 | $29.30 | $28.51 | 830,900 | |
| $28.91 | -0.20 | -0.7% | $29.05 | $29.12 | $28.58 | 1,036,000 | |
| $29.11 | -0.62 | -2.1% | $29.51 | $29.73 | $29.02 | 1,530,000 | |
| $29.73 | +0.15 | +0.5% | $29.26 | $29.83 | $29.15 | 879,300 | |
| $29.58 | -0.99 | -3.2% | $30.36 | $30.38 | $29.28 | 1,336,200 | |
| $30.57 | +0.92 | +3.1% | $30.14 | $30.76 | $29.85 | 1,523,784 | |
| $29.65 | +0.15 | +0.5% | $29.50 | $29.78 | $29.15 | 1,489,609 | |
| $29.50 | +0.46 | +1.6% | $29.08 | $29.62 | $28.80 | 1,093,500 | |
| $29.04 | -1.17 | -3.9% | $30.00 | $30.00 | $28.95 | 1,318,700 | |
| $30.21 | +0.03 | +0.1% | $30.66 | $30.96 | $30.07 | 2,288,100 | |
| $30.18 | +1.17 | +4.0% | $29.14 | $30.25 | $29.05 | 2,053,400 | |
| $29.01 | +0.77 | +2.7% | $28.63 | $29.03 | $28.21 | 1,122,200 | |
| $28.24 | -0.14 | -0.5% | $28.26 | $28.43 | $27.90 | 1,062,600 | |
| $28.38 | -1.07 | -3.6% | $29.75 | $29.75 | $28.36 | 1,507,200 | |
| $29.45 | +0.04 | +0.1% | $29.18 | $29.85 | $28.83 | 1,409,700 | |
| $29.41 | +0.02 | +0.1% | $29.57 | $29.76 | $29.10 | 1,346,500 | |
| $29.39 | +0.18 | +0.6% | $29.00 | $29.65 | $29.00 | 2,726,400 | |
| $29.21 | +0.76 | +2.7% | $28.57 | $29.29 | $28.20 | 1,782,700 | |
| $28.45 | -0.35 | -1.2% | $28.85 | $29.48 | $28.32 | 3,049,800 | |
| $28.80 | +1.65 | +6.1% | $27.96 | $29.17 | $27.80 | 4,549,300 | |
| $27.15 | +1.54 | +6.0% | $25.66 | $27.23 | $25.55 | 2,440,400 | |
| $25.61 | -0.26 | -1.0% | $25.96 | $26.11 | $25.43 | 1,368,100 | |
| $25.87 | -0.68 | -2.6% | $26.44 | $26.44 | $25.35 | 1,534,200 | |
| $26.55 | +0.21 | +0.8% | $26.13 | $26.58 | $25.87 | 1,298,700 |
- Ticker
- NASDAQ:ACAD
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 28, 2026
Acadia Pharmaceuticals to Participate in the UBS Global Biopharma Conference 2026
Latest earnings call · Aug 4, 2026
ACADIA Pharmaceuticals (NASDAQ:ACAD) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Sep 24, 2026
Technical Presentation (September 2026)
Technical · 19 slides
Calls
Upcoming
ACADIA Pharmaceuticals (NASDAQ:ACAD) Q3 2026 Earnings Call
Wed, Nov 04, 2026 · 4:30 PM ET
Register
Replays
ACADIA Pharmaceuticals (NASDAQ:ACAD) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 4:30 PM ET
Watch TranscriptACADIA Pharmaceuticals (NASDAQ:ACAD) Q1 2026 Earnings Call
Wed, May 06, 2026 · 4:30 PM ET
Watch TranscriptACADIA Pharmaceuticals (NASDAQ:ACAD) Q4 2025 Earnings Call
Wed, Feb 25, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Acadia Pharmaceuticals to Participate in the UBS Global Biopharma Conference 2026
Oct 28, 2026
Closed $20.76 (+2.2%) on Oct 29, 2026
Acadia Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 4, 2026
Oct 21, 2026
Closed $20.31 (+0.6%) on Oct 22, 2026
Acadia Pharmaceuticals Announces Allowance of U.S. Patent Covering Weight-Banded Dosing of Trofinetide, extending U.S. patent protections to March 2041
Sep 28, 2026
Closed $20.22 (-1.5%) on Sep 29, 2026
Acadia Pharmaceuticals Announces Phase 3 Enabling Topline Results from Phase 2 RADIANT Study of Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis (ADP)
Sep 24, 2026
Closed $22.18 (-12.8%) on Sep 24, 2026
European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union
Aug 24, 2026
Closed $29.65 (+0.5%) on Aug 24, 2026
Acadia Pharmaceuticals Reports Second Quarter 2026 Financial Results
Aug 4, 2026
Closed $28.80 (+6.1%) on Aug 5, 2026
Acadia Pharmaceuticals to Participate in the Canaccord Genuity 46th Annual Growth Conference
Jul 30, 2026
Closed $25.87 (-2.6%) on Jul 31, 2026
Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis
Jul 20, 2026
Closed $25.09 (-2.0%) on Jul 20, 2026
Acadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 4, 2026
Jul 15, 2026
Closed $25.63 (-1.1%) on Jul 16, 2026
Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer
Jul 6, 2026
Closed $25.77 (-0.8%) on Jul 6, 2026
Decks
Technical Presentation (September 2026)
Technical · 19 slides · Sep 24, 2026
Q2 2026 Earnings Presentation
Earnings · 21 slides · Aug 4, 2026
Q4 2025 Earnings Presentation
Earnings · 20 slides · Feb 25, 2026
Q3 2025 Earnings Presentation
Earnings · 17 slides · Nov 5, 2025
ACADIA Pharmaceuticals Inc. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 27 in the last 12 months · 195 in all · newest Oct 28, 2026 · oldest 2019
- Calls
- 26 calls with a replay · 26 with a transcript · latest Aug 4, 2026
- Decks
- 30 decks · latest Sep 24, 2026
Where ACADIA Pharmaceuticals Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ACAD · Home listing · This page | NASDAQ | United States | USD |
| gettex:DR6 | gettex | Germany | EUR |
| Tradegate:DR6 | Tradegate | Germany | EUR |
| BMV:ACAD | BMV | Mexico | MXN |
| LS Exchange:603035 | LS Exchange | Germany | EUR |
| Lang & Schwarz:603035 | Lang & Schwarz | Germany | EUR |
| Frankfurt:DR6 | Frankfurt | Germany | EUR |
| BIVA:ACAD | BIVA | Mexico | MXN |
| BOATS:ACAD | BOATS | United States | USD |
| LSE:0A4W | LSE | United Kingdom | USD |
| Dusseldorf:DR6 | Dusseldorf | Germany | EUR |
| Munich:DR6 | Munich | Germany | EUR |
| Stuttgart:DR6 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about ACADIA Pharmaceuticals Inc.